ST6GALNAC2 and metastatic malignant neoplasm in the lymph nodes: Sialylation of the T antigen is governed by action of ST6GalNAc-II, and an overexpression of its mRNA level has been correlated to poor patient survival in CRC with lymph node metastases (45).